Literature DB >> 24728497

Crosstalk between fibroblasts and inflammatory cells.

Sophie Van Linthout1, Kapka Miteva, Carsten Tschöpe.   

Abstract

Fibroblasts, which are traditionally recognized as a quiescent cell responsible for extracellular matrix production, are more and more appreciated as an active key player of the immune system. This review describes how fibroblasts and immune cells reciprocally influence the pathogenesis of fibrosis. An overview is given how fibroblasts are triggered by components of the innate and adaptive immunity on the one hand and how fibroblasts modulate immune cell behaviour via conditioning the cellular and cytokine microenvironment on the other hand. Finally, latest insights into the role of cardiac fibroblasts in the orchestration of inflammatory cell infiltration in the heart, and their impact on heart failure, are outlined.

Entities:  

Keywords:  Fibroblast; Heart failure; Innate and adaptive immune response; Myofibroblast

Mesh:

Substances:

Year:  2014        PMID: 24728497     DOI: 10.1093/cvr/cvu062

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  161 in total

1.  Fra-2-expressing macrophages promote lung fibrosis in mice.

Authors:  Alvaro C Ucero; Latifa Bakiri; Ben Roediger; Masakatsu Suzuki; Maria Jimenez; Pratyusha Mandal; Paola Braghetta; Paolo Bonaldo; Luis Paz-Ares; Coral Fustero-Torre; Pilar Ximenez-Embun; Ana Isabel Hernandez; Diego Megias; Erwin F Wagner
Journal:  J Clin Invest       Date:  2019-05-28       Impact factor: 14.808

Review 2.  Integrin-mediated regulation of epidermal wound functions.

Authors:  C Michael DiPersio; Rui Zheng; James Kenney; Livingston Van De Water
Journal:  Cell Tissue Res       Date:  2016-06-28       Impact factor: 5.249

3.  Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis.

Authors:  Christine S Zuern; Britta Walker; Martina Sauter; Malte Schaub; Madhumita Chatterjee; Karin Mueller; Dominik Rath; Sebastian Vogel; Roland Tegtmeyer; Peter Seizer; Tobias Geisler; Reinhard Kandolf; Florian Lang; Karin Klingel; Meinrad Gawaz; Oliver Borst
Journal:  Clin Res Cardiol       Date:  2015-05-26       Impact factor: 5.460

4.  Tissue microenvironment initiates an immune response to structural components of Staphylococcus aureus.

Authors:  Carine Mainzer; Thomas Packard; Sylvie Bordes; Brigitte Closs; Warner C Greene; Peter M Elias; Yoshikazu Uchida
Journal:  Exp Dermatol       Date:  2019-02       Impact factor: 3.960

5.  [New therapy concepts for heart failure with preserved ejection fraction].

Authors:  C Tschöpe; B Pieske
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

6.  One low-dose exposure of gold nanoparticles induces long-term changes in human cells.

Authors:  Priscila Falagan-Lotsch; Elissa M Grzincic; Catherine J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

7.  Specific recruitment of circulating angiogenic cells using biomaterials as filters.

Authors:  Matthew Parlato; James Molenda; William L Murphy
Journal:  Acta Biomater       Date:  2017-04-01       Impact factor: 8.947

Review 8.  Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.

Authors:  Carsten Tschöpe; Sophie Van Linthout; Behrouz Kherad
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

9.  Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis.

Authors:  JoAnn Trial; Celia Pena Heredia; George E Taffet; Mark L Entman; Katarzyna A Cieslik
Journal:  Basic Res Cardiol       Date:  2017-05-06       Impact factor: 17.165

10.  Temporal changes in myocardial collagen, matrix metalloproteinases, and their tissue inhibitors in the left ventricular myocardium in experimental chronic mitral regurgitation in rodents.

Authors:  Daniella Corporan; Daisuke Onohara; Roberto Hernandez-Merlo; Alicja Sielicka; Muralidhar Padala
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.